| Powder River Medical Clinic | |
|
507 North Lincoln Ave Box 489 Broadus MT 59317-0489 | |
| (406) 436-2651 | |
| (406) 436-2652 |
| Full Name | Powder River Medical Clinic |
|---|---|
| Speciality | Clinic/center - Rural Health |
| Location | 507 North Lincoln Ave, Broadus, Montana |
| Authorized Official Name and Position | Leroy N Biesheuvel (PHYSICIAN'S ASSISTANT) |
| Authorized Official Contact | 4064362651 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Powder River Medical Clinic 507 North Lincoln Ave Box 489 Broadus MT 59317-0489 Ph: (406) 436-2651 | Powder River Medical Clinic 507 North Lincoln Ave Box 489 Broadus MT 59317-0489 Ph: (406) 436-2651 |
| NPI Number | 1265605398 |
|---|---|
| Provider Enumeration Date | 04/09/2008 |
| Last Update Date | 04/09/2008 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265605398 | NPI | - | NPPES |
| 90943 | Other | MT | BCBS |
| 0720070 | Medicaid | MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QR1300X | Clinic/center - Rural Health | 17 (Montana) | Primary |
News Archive
Today Biogen Idec and Abbott announced additional results from the SELECT Phase 2b trial, the first of two registrational studies designed to evaluate the investigational compound daclizumab high-yield process in people with relapsing-remitting multiple sclerosis.
Medication adherence alone may not be enough to impact the productivity of employees with chronic conditions such as depression, diabetes, hypertension and coronary artery disease.
Alkermes plc today announced positive topline results from a randomized, double-blind, placebo-controlled phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia. Patients treated once monthly with either 441 mg or 882 mg of aripiprazole lauroxil demonstrated statistically significant reductions from baseline in Positive and Negative Syndrome Scale (PANSS) total scores at week 12, compared to placebo (p<0.001 aripiprazole lauroxil 441 mg, p<0.001 aripiprazole lauroxil 882 mg), which was the prespecified primary endpoint in the study. Based on the positive results from this phase 3 study, Alkermes plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the third quarter of 2014.
Under Michel Landel's initiative, Chief Executive Officer of Sodexo, the 380,000 Sodexo employees across the globe are invited to join forces this month for the annual Sodexo "Servathon".
› Verified 9 days ago
Powder River County Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 507 North Lincoln Avenue, Broadus, MT 59317 Phone: 406-436-2651 Fax: 406-436-2652 | |
Powder River Manor Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 104 North Trautman, Broadus, MT 59317 Phone: 406-436-2646 |